These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32000829)

  • 1. Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients.
    Moore S; Leung B; Wu J; Ho C
    Radiat Oncol; 2020 Jan; 15(1):23. PubMed ID: 32000829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic Ablative Body Radiotherapy Versus Radical Radiotherapy: Comparing Real-World Outcomes in Stage I Lung Cancer.
    Phillips I; Sandhu S; Lüchtenborg M; Harden S
    Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):681-687. PubMed ID: 31377081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Treatment of Stage III NSCLC: The Role of Trimodality Treatment in the Era of Immunotherapy.
    Moore S; Leung B; Wu J; Ho C
    J Thorac Oncol; 2019 Aug; 14(8):1430-1439. PubMed ID: 31002953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definitive chemotherapy and radiotherapy in patients with stage II non-small cell lung cancer: A population-based outcomes study.
    Sampath S; Hall M; Schultheiss TE
    Lung Cancer; 2015 Oct; 90(1):61-4. PubMed ID: 26231092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
    Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).
    Rowell NP; Williams CJ
    Cochrane Database Syst Rev; 2001; (1):CD002935. PubMed ID: 11279780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).
    Rowell NP; Williams CJ
    Cochrane Database Syst Rev; 2001; (2):CD002935. PubMed ID: 11406051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy for stage III non-small-cell lung carcinoma in the elderly (age ≥ 70 years).
    Aridgides PD; Janik A; Bogart JA; Duffy S; Rosenbaum P; Gajra A
    Clin Lung Cancer; 2013 Nov; 14(6):674-9. PubMed ID: 23891240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of stage I Non-Small cell lung cancer (NSCLC) in Ontario: A Population-Based study of patterns of care and Stereotactic Ablative Body radiotherapy (SABR) utilization from 2010 to 2019.
    Ashworth A; Kong W; Owen T; Hanna TP; Brundage M
    Radiother Oncol; 2024 May; 194():110153. PubMed ID: 38364940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical Treatment of Stage II Non-small-cell Lung Cancer With Nonsurgical Approaches: A Multi-institution Report of Outcomes.
    Dudani S; Zhu X; Yokom DW; Yamada A; Ho C; Pantarotto JR; Leighl NB; Zhang T; Wheatley-Price P
    Clin Lung Cancer; 2018 Jan; 19(1):e11-e18. PubMed ID: 28711384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation therapy of stage I and II non-small cell lung cancer (NSCLC).
    Zierhut D; Bettscheider C; Schubert K; van Kampen M; Wannenmacher M
    Lung Cancer; 2001 Dec; 34 Suppl 3():S39-43. PubMed ID: 11740992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.
    Sibley GS; Jamieson TA; Marks LB; Anscher MS; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):149-54. PubMed ID: 9422571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
    Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical radiotherapy or chemoradiotherapy for inoperable, locally advanced, non-small cell lung cancer: Analysis of patient profile, treatment approaches, and outcomes for 213 patients at a tertiary cancer center.
    Shrimali RK; Nallathambi C; Saha A; Das A; Prasath S; Mahata A; Arun B; Mallick I; Achari R; Dabkara D; Thambudorai R; Chatterjee S
    Indian J Cancer; 2018; 55(2):125-133. PubMed ID: 30604722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer.
    Ostheimer C; Bache M; Güttler A; Reese T; Vordermark D
    BMC Cancer; 2014 Nov; 14():858. PubMed ID: 25416631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of 49 patients who survived for 5 years following radical radiation therapy for non-small cell lung cancer: the potential for cure.
    Mac Manus MP; Wada M; Matthews JP; Ball DL
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):63-9. PubMed ID: 10656374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy With Curative Intent in Patients With Early-stage, Medically Inoperable, Non-Small-cell Lung Cancer: A Systematic Review.
    Falkson CB; Vella ET; Yu E; El-Mallah M; Mackenzie R; Ellis PM; Ung YC
    Clin Lung Cancer; 2017 Mar; 18(2):105-121.e5. PubMed ID: 27908621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
    Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
    J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.